Lexaria Bioscience (LEXX) Return on Assets (2017 - 2026)

Lexaria Bioscience has disclosed Return on Assets across 10 years of filings, most recently posting 0.02% for Q1 2026.

• Return on Assets for Q1 2026 came in at 0.02%, changed 0.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 0.02% (changed 0.0% YoY), and the FY2025 annual result was 0.02%, down 1.0% from the prior year.
• Return on Assets came in at 0.02% for Q1 2026 at Lexaria Bioscience, up from 0.02% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2022 to a low of 0.54% in Q1 2024.
• The 5-year median for Return on Assets is 0.02% (2026), against an average of 0.05%.
• Across the five-year window, Return on Assets slumped 47 bps in 2024 and jumped 53 bps in 2025, its largest moves.
• Lexaria Bioscience's Return on Assets stood at 0.02% in 2022, then tumbled by 134 bps to 0.04% in 2023, then surged by 79 bps to 0.01% in 2024, then plunged by 169 bps to 0.02% in 2025, then rose by 28 bps to 0.02% in 2026.
• The last three Return on Assets figures came in at 0.02% (Q1 2026), 0.02% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.